Azitra, Inc. (AZTR)
0.7425
+0.02
(+2.40%)
USD |
NYAM |
Nov 06, 10:34
Azitra Net Income (Quarterly) : -3.348M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.348M |
| March 31, 2026 | -3.927M |
| December 31, 2025 | -2.234M |
| September 30, 2025 | -2.764M |
| June 30, 2025 | -2.889M |
| March 31, 2025 | -3.068M |
| December 31, 2024 | -2.393M |
| September 30, 2024 | -1.010M |
| Date | Value |
|---|---|
| June 30, 2024 | -2.632M |
| March 31, 2024 | -2.933M |
| December 31, 2023 | -2.454M |
| September 30, 2023 | -1.943M |
| June 30, 2023 | -4.430M |
| March 31, 2023 | -2.457M |
| June 30, 2022 | -1.890M |
| March 31, 2022 | -2.326M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -- |
| Exicure, Inc. | -1.121M |
| Century Therapeutics, Inc. | -34.55M |
| Absci Corp. | -33.21M |
| Celularity, Inc. | 0.546M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.348M |
| EPS Diluted (Quarterly) | -1.734 |
| Enterprise Value | -1.923M |
| Earnings Yield | -1.76K% |
| Normalized Earnings Yield | -1758.75 |